Global Diverticulitis Disease Market Analysis 2025–2029: Opportunities for Strategic Growth

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Diverticulitis Disease Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The diverticulitis disease market size has shown significant expansion over recent years. It is anticipated to expand from $1.85 billion in 2024 to $2.02 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.3%. This historical growth can be linked to factors such as an aging population, prevailing dietary habits, the prevalence of obesity, and improvements in medical imaging technology.

The diverticulitis disease market is set for significant expansion over the next few years. It is anticipated to achieve a valuation of $2.91 billion by 2029, progressing at a compound annual growth rate (CAGR) of 9.5%. This projected increase is largely due to advancements like colonoscopy and endoscopy, a rise in awareness, the adoption of minimally invasive procedures, and personalized medicine. Key developments expected within this timeframe include preventive measures, improved diagnostic instruments, cooperative care frameworks, and alterations in healthcare policy.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12990&type=smp

Which Drivers Are Shaping The Diverticulitis Disease Industry’s Market Share?

The increasing incidence of smoking addiction is anticipated to fuel the expansion of the diverticulitis disease market in the future. This rise in smoking addiction stems from factors such as aggressive marketing tactics, societal acceptance, stress, and nicotine’s highly addictive properties. Furthermore, the widespread availability of e-cigarettes and vape devices, coupled with social pressures and peer influence, particularly among younger demographics, also contributes to elevated smoking rates. Smoking drives the demand for diverticulitis treatment by heightening the risk of developing diverticular disease, as it compromises blood flow to the colon and can result in more severe complications, thereby generating a greater need for diagnostic tools and therapeutic interventions. For example, data from Statistics Canada, a Canada-based government agency, indicated that in July 2022, cigarette production saw a 5.8% increase compared to June 2021. Additionally, the overall volume of cigarettes sold climbed by 1.3% from May 2022, reaching 1.4 billion in June 2022. Consequently, the growing prevalence of smoking addiction is set to propel the growth of the diverticulitis disease market.

How Is The Diverticulitis Disease Market Classified Into Different Segments?

The diverticulitis diseasemarket covered in this report is segmented –

1) By Type: Uncomplicated; Complicated

2) By Diagnosis: Computed Tomography (CT) Scan; Ultrasound; Urine Test; Blood Test

3) By Treatment: Medications; Surgery; Supportive care; Penicillin Antibiotic; Antibiotics; Dietary Supplements; Intravenous (IV) Fluids

4) By End-User: Specialty Centers; Hospitals; Research centers

Subsegments:

1) By Uncomplicated: Outpatient Treatment; Dietary Management; Antibiotic Therapy

2) By Complicated: Hospitalization; Surgical Intervention; Intravenous Antibiotics; Abscess Drainage

Which Trends Are Impacting The Diverticulitis Disease Market?

Leading companies within the diverticulitis disease market are engaged in the development and approval of innovative drugs to sustain their competitive edge. Such pharmaceutical advancements promise more effective treatments for diverticulitis, thereby lowering the risk of complications and enhancing patient outcomes. For example, in April 2023, the United States Food and Drug Administration, a US federal entity, granted approval to Seres’ microbiota drug for recurrent gut infections. This drug aims to treat persistent gut infections and prevent the reoccurrence of Clostridioides difficile (C. diff.) infections in adults aged 18 and over. The approval of Vowst was supported by a clinical trial that included 346 patients suffering from recurrent CDI. The trial concluded that patients who received Vowst experienced a notably reduced chance of infection recurrence compared to those administered a placebo. The medication is taken orally and is formulated with microbiota containing Firmicutes spores, recognized for contributing to a robust microbiome capable of resisting C. diff. colonization.

Which Leading Players Are Enhancing Their Diverticulitis Disease Market Presence Worldwide?

Major companies operating in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report

What Are The Regional Market Dynamics Impacting The Diverticulitis Disease Industry?

North America was the largest region in the diverticulitis disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diverticulitis disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Diverticulitis Disease Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12990&type=smp

Browse Through More Reports Similar to the Global Diverticulitis Disease Market 2025, By The Business Research Company

Inflammatory Bowel Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Irritable Bowel Syndrome Ibs Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/irritable-bowel-syndrome-ibs-treatment-global-market-report

Gastric Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795